Nasdaq:US$19.90 (-0.19) | HKEX:HK$31.85 (+0.45) | AIM:£3.15 (-0.09)
News & Presentations
Previous Article   |   Next Article
Presentations | 12 Oct 2023

Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor